Delivery Order SPE2DB22D2007-SPE2DB25FJ1VV
Award Date
5/28/25
Potential Completion Date
5/29/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DALIRESP 500 MCG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,726.44 and a period of performance through January 3, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of DALIRESP 500 MCG TABLET 30S. The contract has a ceiling value of $33,557.38 and runs through February 4, 2025. The contract is a Firm Fixed Price type and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of DALIRESP 500 MCG TABLET 90S. The contract has a ceiling value of $5,209.62 and runs through February 4, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $14,139.70 firm fixed-price contract is for the supply of 4557963117 - DALIRESP 500 MCG TABLET 30S. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DALIRESP 500 MCG tablets. The contract is a Firm Fixed Price delivery order with a ceiling value of $2,547.18 and a period of performance through March 13, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $3,044.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,093,224 units of Daliresp 500 MCG tablets in a 90-count package. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a period of performance ending on May 1, 2025. The contract is not designated as a set-aside. Amerisourcebergen...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,430.17 firm-fixed-price contract is for the delivery of 90-count bottles of the medication Daliresp 500 MCG Tablet. The contract has a period of performance through May 8, 2025 and was awarded on May 7, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any subcontractors. This delivery order is part of...
This federal contract award, with ID SPE2DB20D2104|SPE2DB23FS49C, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 6, 2023. The $3,667.14 firm-fixed-price delivery order is for the supply of DALIRESP 500 MCG TABLET 90S, a pharmaceutical product. The contract has a completion date of March 7, 2023 and is not designated under any set-aside category. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Daliresp 500mcg 90s medication. The contract has a ceiling value of $41,684.33 and a performance period through May 30, 2025. It is a firm-fixed-price delivery order contract, which indicates a pre-determined price for the medication. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 90-count tablets of DALIRESP 500 MCG. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency, and has a ceiling value of $10,864.32. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive...